Von Willebrand Factor Antigen Is Less Sensitive than Ristocetin Cofactor for the Diagnosis of Type I von Willebrand Disease -Results Based on an Epidemiological Investigation
Received 26 January 1990
Accepted after revision28 May 1990
25 July 2018 (online)
Recently, in an epidemiological investigation involving 1,218 children aged 11-14, we demonstrated that the prevalence of von Willebrand’s disease, based on a low ristocetin cofactor activity (RiCof) in children with a personal and/or family history of hemorrhage, was at least 1% (Blood 1987; 69: 454). All the diagnosed cases had multimeric patterns typical of type I von Willebrand’s disease (vWd). Since standardization of RiCof is difficult and the test is not easily performed in a clinical laboratory, we measured von Willebrand factor antigen (vWf: Ag) in all available unthawed plasma samples of previously investigated children by ELISA, to assess the relative sensitivity of this more simple test for diagnosing vWd.
Separate normal ranges were calculated by non-parametric methods for 0 and non-0 subjects, and for children and adults, since values were higher in non-0 subjects and in children.
Taking into account the 90% confidence interval around the lower limit of the normal range, 7 (50%) of the 14 cases diagnosed by RiCof were detected by vWf: Ag. Furthermore, two new cases would have been diagnosed by vWf: Ag, leading to a relative Ag/ RiCof global sensitivity of 64%. A similar figure was obtained when the two tests were compared in the group of relatives of the affected children.
In conclusion, measurement of vWf: Ag seems to be definitely less sensitive than the RiCof assay for detecting patients with vWd, even in type I patients, and RiCof remains the test of choice for screening for vWd in hemorrhagic patients.
- 1 Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood 1987; 69: 454-459
- 2 Miller CH, Lenzi R, Breen C. Prevalence and gene frequency of von Willebrand’s disease among U.S. adults. Blood 1987 70. 377 (abstr)
- 3 Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895-904
- 4 Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand’s disease: variability versus “variants”. Blood 1980; 56: 712-715
- 5 Kirkwood TB L, Snape TJ. Statistics of bioassay of blood coagulation factors. In: Human Blood Coagulation, Haemostasis and Thrombosis Biggs R, Rizza CR. (eds) Blackwell; London: 1984. p 542
- 6 Barrowcliffe TW, Tydeman MS, Kirkwood TB L, Thomas DP. Standardization of factor VIII - III. Establishment of a stable reference plasma for factor VUI-related activities. Thromb Haemostas 1983; 50: 690-696
- 7 Reed AH, Henry RJ, Mason WB. Influence of statistical method used on the resulting estimate of normal range. Clin Chem 1971; 17: 275-284
- 8 Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand’s disease. I. Phenotypic variation within families. Blood 1979; 54: 117-136
- 9 Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand’s disease. II. Optimal assignement of the heterozygous genotype (diagnosis) by discriminant analysis. Blood 1979; 54: 137-145
- 10 Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-1695